Early diagnosis and treatment of thrombocytopenia and hypofibrinogenemia in cardiac surgery by novel viscoelastic testing devise,Quantra-Qplus system

Early diagnosis and treatment of thrombocytopenia and hypofibrinogenemia in cardiac surgery using novel viscoelastic testing devise,Quantra-Qplus system

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1032220207

Enrollment

Registered

2022-07-08

Start date

2022-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing caridiovascular surgery with cardiopulmonary bypass

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with written informed consent 2)Caridiovascular surgery patients using cardiopulmonary bypass 3)Patients over 18 years of age at the time of concent

Exclusion criteria

Exclusion criteria: 1)Patients undergoing emergency surgery 2)Patients who may be pregnant 3)Heart transplant surgery. 4)Cardiac surgey reoperation .

Design outcomes

Primary

Measure	Time frame
Estimation of cut-off values for FCS(fibrinogen clot stiffness) and PCS(platelet clot stiffness)measured by Quantra Qplus system to predict a blood fibrinogen concentration of less than 150mg/dl and a blood platelet count of less than 70000/mm3	—

Secondary

Measure	Time frame
Correlation of blood fibrinogen levels with Quantra-Qplus system measurements of FCS. Correlation of blood platelet counts with Quantra-Qplus system measurements of PCS .	—

Contacts

Public ContactHiroaki Suzuki

Dokkyo Medical University Saitama Medical Center ,Department of Anesthesia

hiroszk8@dokkyomed.ac.jp+81-489651111

Outcome results